PureTech Health plc
Income Statement
| Line Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Revenue | $4.8M | $3.3M | $15.6M | $17.4M | $11.8M | $9.8M | $20.7M |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — |
| Operating Income | $-136.1M | $-146.2M | $-197.8M | $-150.3M | $-119.5M | $-135.4M | $-104.0M |
| Operating Margin | -2,818.9% | -4,390.4% | -1,266.5% | -864.3% | -1,015.7% | -1,380.6% | -501.3% |
| Interest Expense | — | — | — | — | $2.4M | $2.5M | $0 |
| Pretax Income | $23.8M | $-36.1M | $-92.8M | $-59.0M | $19.0M | $478.5M | $-68.4M |
| Income Tax Expense | $-4.0M | $30.5M | $-55.7M | $3.8M | $14.4M | $112.4M | $2.2M |
| Net Income | $53.5M | $-65.7M | $-50.4M | $-60.6M | $6.0M | $421.1M | $-43.7M |
| Net Margin | 1,108.3% | -1,972.9% | -322.4% | -348.3% | 50.9% | 4,294.3% | -210.4% |
| EPS (Basic) | $0.21 | $-0.24 | $-0.18 | $-0.21 | $0.02 | $1.49 | $-0.16 |
| EPS (Diluted) | $0.21 | $-0.24 | $-0.18 | $-0.21 | $0.02 | $1.44 | $-0.16 |
| Shares Outstanding (Basic) | 239.4M | 271.9M | 278.6M | 287.8M | 285.9M | — | — |
| Shares Outstanding (Diluted) | 239.4M | 271.9M | 278.6M | 287.8M | 285.9M | — | — |
| Dividends Per Share | — | — | — | — | — | — | — |